chrisvoncsefalvay/vaers-outcomes huggingface dataset:
NEEDLE WAS VERY PAINFUL GOING IN.; DARK LINE / where THE INJECTION SITE WAS.; BLEEDING DOWN MY ARM.; REDNESS; SWELLING; MY BICEP IS EXTREMELY SORE--; This case was reported by a consumer and described the occurrence of injection site pain in a 60-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included visual impairment.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced injection site pain, injection site discoloration, injection site hemorrhage, injection site erythema, injection site swelling and pain in arm. On an unknown date, the outcome of the injection site pain, injection site discoloration, injection site hemorrhage, injection site erythema, injection site swelling and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, injection site discoloration, injection site hemorrhage, injection site erythema, injection site swelling and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient was visually impaired and thus reported in caps and large bold font. The patient received 1st dose of Shingrix and experienced redness and swelling and also had dark line measuring approximately 1 and half inch running diagonally across his/her left bicep at injection site. The patient reported that the needle was very painful and there was bleeding at time of vaccination. The patient's bicep was extremely sore, much more than he/she expected. The patient enquired about the dark line and also enquired that the pharmacist injected her vaccine correctly.
Pt recvd 3 doses of Engerix-B, 3rd dose given 21NOV90; 19FEB90 titers indicated no seroportection p/3 doses; 4th dose given 16MAY91;
Facility gave patient an expired booster shot (it expired on 27OCT2021); Facility gave patient a 2nd booster shot to patient within one hour from the 1st booster shot both on 28OCT2021; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Facility gave patient an expired booster shot (it expired on 27OCT2021)) and EXTRA DOSE ADMINISTERED (Facility gave patient a 2nd booster shot to patient within one hour from the 1st booster shot both on 28OCT2021) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Facility gave patient an expired booster shot (it expired on 27OCT2021)) and EXTRA DOSE ADMINISTERED (Facility gave patient a 2nd booster shot to patient within one hour from the 1st booster shot both on 28OCT2021). On 28-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Facility gave patient an expired booster shot (it expired on 27OCT2021)) and EXTRA DOSE ADMINISTERED (Facility gave patient a 2nd booster shot to patient within one hour from the 1st booster shot both on 28OCT2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.
did not go back to get the second dose of the series; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose in 2018).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: did not go back to get the second dose of the series). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 25-Oct-2023 Reporter called with question about Shingrix.  Did not consent to follow-up. Till the time of reporting, the patient did not receive second dose of Shingrix, which led to incomplete course of vaccination.
Morbidiform Rash present on abdomen, trunk and back. Symptoms lasted for 4 days. I also had fever of 100.2F for 1 night which resolved with Tylenol.
patient received flu shot  stated felt fine got up and left booth to meet her mom we were all talking  for approximately 5 minutes  all of a sudden she said she didn't feel well and got pale her mother and I sat her in chair  did not lose consciousness felt hot and sweaty no throat closure rash etc did say her vision was off (black and rainbow) called 911 paramedics came and she walked to stretcher and left   spoke to mom later that night and said she was fine
When I caught COVID-19 I had mild symptoms. I had a mild headache, some upper respiratory congestion, a runny nose, and sneezing. I took acetaminophen to treat my symptoms. I was also mildly fatigued. My doctor prescribed paxlovid. After I had recovered from the acute, beginning phases of COVID-19 I was still  experiencing some fatigue, mild congestion, and occasional coughing that has lingered. I did have a low grade fever of about 97 to 98.8 degrees.
Patient reported "seeing dots," a metallic taste in her mouth, pressure in her chest and feeling as though she was "suffocating from the inside." Patient was given 50mg of diphenhydramine and per her request an ambulance was called and the patient was taken to the hospital.
PATIENT STATES AFTER RECIEVING VACCINATIONS, HE DEVELOPED A RASH AND ITCHING ALL OVER HIS THIGH, BUTTOCKS, ARM WITH LIGHT BLISTERS.
Local redness, swelling and pain at site of injection within 24 hrs. of administration. Symptoms resolved within 2 days.
Fatigue started around 6pm and started to feel hot. As the night progressed I developed body aches and chills. Weakness. Just walking was difficult because I felt so wiped out. My arm was very painful with my hand tingling. Fever spiked at 102.  Last until about 2 am and I fell asleep. Woke up with fatigue and feeling warm. No fever. Temp was 98.8. I had no appetite. Fatigue lasted the day. Woke up on Saturday and felt back to pre vaccine state
When our facility received the Covid - 19 vaccine, was told that the exp. date for the vaccine was 9 months from  date on the box. Which made the exp. date 5/31/22. On 5/20/22 Contacted me stating that we have given exp. vaccines to patients and that the exp. date was 10 weeks from the date the vaccine was received which would have been 5/2/22. Thus we unknowingly gave exp vaccine to patient.   Patient tolerated vaccine well, no adverse effects have been reported.
Acute hearing loss. Feeling of fullness in my left ear with partial hearing loss. Began experiencing it a few hours after vaccine administration. Nothing else in my day could have explained the hearing loss. Pseudoephedrine, naproxen, and tylenol have not helped. Nothing has helped to relieve it.  I called the nurse triage line a few days after the event and they suggested pseudoephedrine and to call back the next week if things have not resolved.
pt recv vax & devel hives;the rash was described as red whelps & itching;tx w/DPH which seemed to help pt;
This spontaneous report as received from a nurse refers to patients of unknown demographics. The patients medical history was not reported. On an unknown date, the patients were vaccinated with an improperly stored dose of PROQUAD recombinant human albumin (rHA) (Strength, dose, frequency, route and anatomical location were not reported) of lot # N001488 with an expiry date of 12-JUL-2018, for prophylaxis. Co-suspect therapy included sterile diluent (Strength, dose, frequency and route were not reported) of lot # N006324 with an expiry date of 19-JUL-2024. There were no concomitant therapies reported. The vaccines were exposed to - 2.4 degree Celsius (C) for 1 hour and 7 minutes. There was previous temperature excursion which involved exposure to - 6 degree Celsius (C) for 2 hours. Digital data logger was involved. There were no adverse effects reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. The therapy type is recombinant human albumin (rHA) for PROQUAD.; Sender's Comments: US-009507513-1708USA013663:
I started feeling mildly severe pain in my lower back and left hip 2 days after receiving the vaccine. I had a hip replacement a few years ago and it was very painful and it was about 10 days until it subsided.
Severe Knee pain and days she can't even walk. Still not any better. We have seen several drs and have several more apps ahead of us
Information has been received from a pharmacist concerning a patient who on 31 January 2006, was vaccinated with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck). On 18 February 2006, the patient developed a chickenpox rash. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
After H1N1 vaccine, next day began intense body wide itching with red fine rash, lasting for near 2 months.  Required MD to prescribe Zyrtec and Triamcinolone cream for treatment, have used meds for 2 months.
Standard symptoms of a sore arm; Occasionally a headache; Mild fever; This case was reported by a consumer via other manufacturer and described the occurrence of pain in arm in a 59-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu unspecified (Influenza vaccine) for prophylaxis, MMR (MMR vaccine) for prophylaxis, COVID-19 VACCINE for prophylaxis, DIPHTHERIA VACCINE TOXOID, TETANUS VACCINE TOXOID (DT (DIPHTHERIA AND TETANUS TOXOIDS VACCINE)) for prophylaxis, TYPHOID VACCINE (TYPHOID) for prophylaxis and YELLOW FEVER VACCINE (YELLOW FEVER) for prophylaxis.   On an unknown date, the patient received Shingrix, Influenza vaccine, MMR vaccine, COVID-19 VACCINE, DT (DIPHTHERIA AND TETANUS TOXOIDS VACCINE), TYPHOID and YELLOW FEVER. On an unknown date, unknown after receiving Shingrix, Influenza vaccine and MMR vaccine, the patient experienced pain in arm, headache and fever. On an unknown date, the outcome of the pain in arm, headache and fever were unknown.   It was unknown if the reporter considered the pain in arm, headache and fever to be related to Shingrix, Influenza vaccine and MMR vaccine.     Linked case(s) involving the same patient: US2022AMR121345   Additional Information: GSK receipt date- 18-Aug-2022 and 24-Aug-2022 Reporter's comment: The patient never had a serious reaction to any vaccine (e.g. influenza, Covid-19, MMR, DT, typhoid, Shingrix and yellow fever). The patient experienced except the standard symptoms of a sore arm and occasionally a headache or a mild fever. The lot number was not provided. Any other additional information was not provided (sample size, etc.). On an unknown date, unknown after receiving Covid-19 Vaccine, DT (Diphtheria and Tetanus toxoids vaccine, Typhoid and yellow fever, the patient experienced pain in arm, headache and fever.  It was unknown if the reporter considered the pain in arm, headache and fever to be related to Covid-19 Vaccine, DT (Diphtheria and Tetanus toxoids vaccine, Typhoid and yellow fever.    The reporter did not consent to follow up.; Sender's Comments:  US-GSK-US2022AMR121345:Same reporter.
2" round red painful ring around site of injection. After 2 days increased to 3 inches at day 3.
low back pain; swollen arm; hurting arm; red arm; This case was reported by a consumer via call center representative and described the occurrence of low back pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax.   On 20th February 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced low back pain, swelling arm, pain in arm and erythema of extremities. On an unknown date, the outcome of the low back pain, swelling arm, pain in arm and erythema of extremities were unknown.   It was unknown if the reporter considered the low back pain, swelling arm, pain in arm and erythema of extremities to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter called back asking about best time to receive 2nd dose within the 2 to 6 months and if any adverse event worse with 2nd dose than 1st dose.  The patient continues to have lower back back pain since after his first dose.  The patient had not reported the events to his physician still.  The patient also noted he had received the  The patient plans to get his 2nd dose the day after reporting after his first dose  The reporter thought it would be nice, when somebody had an arm that's swollen, or hurting, or red, to tell them what to do about it, like put on heat, put on cold, as they know, try to exercise the arm, or keep the arm immobile, and not told the patient to go see their doctor, because you administered the vaccine, you know, there should be some basic guidelines that you could tell the patient if he was in pain with his arm. This case has been linked with US2019AMR073880, reported by same reporter.
10 minutes after injection I developed tingling to the left side of my face, initially only effecting my lips and mouth.  This progressed over the next 24 hours to include my eye, and cheek. It continued to progress to my forehead and downward my left arm 30 hours post injection.   I sought medical attention and was diagnosed with parsesthesis.  30 hours post vaccine when the tingling was at its worst I developed a fever, muscle aches, and general malaise, I treated with 600mg ibuprofen PO. The tingling now 48 hours post vaccine has improved however is not completely resolved.
A report was received from a health care professional on 25 November 2003, concerning a 30 month old female vaccinee who inadvertently received Fluvirin on 21 November 2003. On 21 November 2003 the vaccinee inadvertently received 0.25 ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037, PJP200400036.
Mom states pt vomited x 5, approx 3 1/2 hrs post/vax. No fever or other sx's. Pt slept well next day. MD states it is an adverse rxn. Parent's came down w/flu the next day. Per mom, 1/19/00, she thinks it may have been the Flu.
Chills; Body ache; incredible headache; intense and prolongued nausea; I felt exhausted; Fever; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (Chills), MYALGIA (Body ache), HEADACHE (incredible headache), NAUSEA (intense and prolongued nausea) and FATIGUE (I felt exhausted) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. G10A21A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy (Mild allergic to latex-red extremely itchy rash) and Paralysis legs (partial paralysis in both legs from traumatic injuries) since 1995. Concomitant products included FINASTERIDE from 11-May-2020 to an unknown date, VITAMIN E [VITAMIN E NOS], VITAMIN D3, PROBIOTICS NOS and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), MYALGIA (Body ache), HEADACHE (incredible headache), NAUSEA (intense and prolongued nausea), FATIGUE (I felt exhausted) and PYREXIA (Fever). At the time of the report, CHILLS (Chills), MYALGIA (Body ache), HEADACHE (incredible headache), NAUSEA (intense and prolongued nausea), FATIGUE (I felt exhausted) and PYREXIA (Fever) had resolved.            No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable   This case was linked to MOD-2021-032966 (Patient Link).
1. Patient was administered Pfizer monovalent covid 19 vaccine after the authorization for use expired April 18, 2023. 2. Patient was prescribed Pfizer Bivalent Covid 19 vaccine and received Pfizer monovalent in error.
Lateral aspect of upper left thigh localized non tender faintly erythematous from non fluctuating non mobile 10 cm in diameter swelling at site of immunization. Two smaller firm swelling purplish about 1cm in diameter firm non tender on lateral right upper thigh.
03/13/202021    4:30am woke up with flu like symptoms and fever.  Fatigued for several days following.  Which I understand are typical. Weeks later I started to notice my heart  fluttering and having heart palpitations, then heavy heart beats.   I had a scheduled physical with my doctor on May 26, 2023.  They performed a routine EKG.  I informed my doctor that I noticed the heart palpitations and fluttering after having the vaccine.  I have also been fatigued as well.  My doctor ordered a 48 hour Holter Test.
Arm redness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm redness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Arm redness). At the time of the report, ERYTHEMA (Arm redness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
It was discovered that the MA was improperly giving the rotavirus monovalent vaccine and only giving the diluent of rotavirus vaccine instead of mixing the diluent with the vial of the rotavirus vaccine and administering that. The clinic was able to track back which patients this affected. Patients on this date may have gotten the diluent only or the proper vaccine based on counts of abnormal diluent and reconstitute vaccine vials. The mother of patient was notified. Provider discussed the need to get patient vaccinated next wk or 2. Mother expressed her understanding and scheduled for Monday at 8:45 or 9AM as a nurse visit. Occurrence date 11/8/21.
Pt became SOB and dizzy. Vital signs stable. She was put on O2 and given po benadryl 25 mg; sent to er for persistent sob and later discharged home
Patient developed chills, nausea and was dry heaving, which resulted in a syncopal episode with LOC for 10-15 seconds.
Guillan barre syndrome.  11/12/09 Medical records and Discharge summary recieved for DOS 10/05-10/10. Final DX: Guillan-Barire.  2 wks progressive ascending weakness, wobbly gait, paresthesias.  HA, fever, fatigue. Dble vision. Neck pain. Vomiting. Swallowing diff. Night terror.  IVIG x3. Improved but absent reflexes on d/c. Home PT. Neuro follow-up.  ICD9 COdes: 357.08
Reported Symptoms: Shoulder/Neck pain, achy, chills, headache Date of Onset: 1/9. Symptoms persist for 2-3 days then abate for a day or two before reappearing, ongoing Medication taken for Symptoms: Tylenol
Medical Director called and spoke with patient on 3/5/2021 who reported she states she came into the Library COVID vaccine PCO on 2/26/21 and states she received the vaccine by an EMT who stuck the needle into a rotator cuff and now has a frozen arm. She went in to see her PCP and was provided cortisone for the swelling. Advised patient to continue to follow up with PCP and that we will report this to VAERS. Also advised patient  she can be seen for her second dose at one of the PH clinics and it should be given in the opposite arm.
The patient presented for a "COVID Booster" she was given one. She is not immunocompromised and not of the age group approved for booster. She inadvertently received a 3rd (total) dose.
Headache, SkinRash, Rash, UrticariaPruritus, Diarrhea, itching/rash bilateral anterior arms, chest area Narrative:
Redness, Itching & Swelling started immediately. Then 24 hours after injection Chills, Fever, Headache, Flu-like feeling, increased Muscle Soreness. Injection site raised, hot & red. This started fairly soon after shot was received.   The area around the injection site was 1/2 of a golf ball in size, with the redness area expanding from the back of my upper arm to my elbow in length and 4"-5" in width. Muscle soreness continued for 1 week.  Benadryl helped itchiness.
dizziness, nausea immediately after shot    lasted 4 hours    fatigue, headache later lasted 36 hours
Fever above 103 and has not come down 2 days later. I have been giving tylenol and motrin in order to keep the fever down.
Expired vaccine given on accident due to pharmacy given us 3 different expiration dates. We used not knowing it was expired.
Immediately after immunizations child vomited and became urticarial, mild facial edema. HR increased to 170's RR increased to 50's and Pulse OX to 93% --> gave ZYRTEC - vomited that but HR decreased to 146, hives began fading pulse ox to 96% EMS transported to ED - BENADRYL, EPI PEN for home use and f/u 1 wk.
Vaccine on Friday 1/28. Reaction began morning of Sunday 1/30. Swelling and sore at injection site. Became swollen and very itchy and red by Monday, January 31. By February 1, the size of reaction at injection site spread to a size larger than my adult hand (from near shoulder to elbow and half of the circumference of my arm).
OCT90 pt exp light-headedness & in NOV90 devel arthralgia following vax 15OCT90; Later recovered; No further details were provided;
knot on arm; sore arm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (knot on arm), MYALGIA (sore arm) and FATIGUE (fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE NODULE (knot on arm), MYALGIA (sore arm) and FATIGUE (fatigue). At the time of the report, VACCINATION SITE NODULE (knot on arm), MYALGIA (sore arm) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information included tylenol.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: NNI, patient does not recall dates of vaccination, patient declined to give email and disconnected the call
Moderna COVID-19 Vaccine EUA Developed round rash at injection site as well as over entire abdobem, chest, back, arms and tops of legs.  Rash is mildly itchy and has not required any treatment.  Rash has very prominent red welts.